Cas:926-61-4 3-oxopropanoic acid manufacturer & supplier

Chemical Name:3-oxopropanoic acid

CAS.NO:926-61-4

Synonyms:Malonaldehydic acid;formalin-acetic acid;3-Oxopropanoic acid;3-Oxo-propionsaeure;formyl acetic acid;malonate semialdehyde;3-oxo-propionic acid;malonic semialdehyde;Propanoic acid,3-oxo

Molecular Formula:C₃H₄O₃

Molecular Weight:88.06210

HS Code:2918300090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:237.3ºC at 760mmHg

Density:1.258g/cm3

Index of Refraction:1.419

PSA:54.37000

Exact Mass:88.01600

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Malonaldehydic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Propanoic acid,3-oxo physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,formalin-acetic acid Use and application,Malonaldehydic acid technical grade,usp/ep/jp grade.

Related News: He added that the government raised the travel advice warning to level four, the highest, meaning they’re now advising people not to travel to mainland China. The warning aims to address ��the issue of the human-to-human transmission of the coronavirus.�� 3-oxopropanoic acid manufacturer The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774. 3-oxopropanoic acid supplier Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity. 3-oxopropanoic acid vendor Analysts at Jefferies, meanwhile, said the FDA accelerated approval for Aduhelm, which was based on a surrogate endpoint of amyloid beta plaque reduction (and not clinical benefit) “has implications for ongoing AD studies,” most notably, it reckons, for Roche’s phase 3 GRADUATE test for its anti-amyloid-beta candidate gantenerumab, “as a much lower hurdle than demonstrating clear cognitive benefit” has now become precedent. Jefferies, still cautious, said it remains “unclear what stance FDA may take for the field if GRADUATE fails on cognition despite significant Abeta reductions,” but says it’s probably not going to revive Roche-AC Immune’s anti-amyloid-beta candidate crenezumab, which saw its late-stage CREAD trials discontinued for futility but which is currently in an Alzheimer’s prevention study. 3-oxopropanoic acid factory The Wuhan coronavirus has brought back memories of the 2003 outbreak of the severe acute respiratory syndrome, known as SARS, which infected more than 8,000 people and killed 774.